Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Back to team page
Coleen Long
Director
With a background in clinical, academic, and consumer research, Coleen brings to every project unique, creative insights and an eye for detail. Our clients benefit from her passion for understanding the needs of special populations to develop tools that improve overall quality of life. Coleen has leveraged multiple methods and approaches to lead research across a wide range of industries, including medical technology, commercial products, entertainment, and mental health. Coleen has a BS in Clinical Psychology from the University of Illinois at Urbana-Champaign.
Bold facts
Learn more about
Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight:

In your spare time (or if you had spare time), you would absolutely do this:
How long have you been in the UX field?

You cannot start the day without doing this...
Your favorite city in the world is...and why?

Your ultimate celebrity dinner party guest list would include:

Do you have a long-term personal or professional goal you'd like to share?
Read our team’s latest bold insights
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.
5 takeaways for human factors practitioners from the HFES Health Care Symposium FDA workshops
Healthcare symposium provides clarity for interpretation of FDA guidance documents related to human factors engineering.